Research Study Purpose Type - TTL Representation

This page is part of the HL7 Terminology (v7.2.0: Release) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions
: Research Study Purpose Type

Active as of 2026-04-14
Maturity Level: 1
Raw ttl | Download

@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

 a fhir:CodeSystem ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "research-study-purpose-type"] ; # 
  fhir:meta [
    ( fhir:profile [
fhir:v "http://hl7.org/fhir/StructureDefinition/shareablecodesystem"^^xsd:anyURI ;
fhir:link <http://hl7.org/fhir/StructureDefinition/shareablecodesystem>     ] )
  ] ; # 
  fhir:language [ fhir:v "en"] ; # 
  fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem research-study-purpose-type</b></p><a name=\"research-study-purpose-type\"> </a><a name=\"hcresearch-study-purpose-type\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"http://hl7.org/fhir/R5/shareablecodesystem.html\">Shareable CodeSystem</a></p></div><p>This case-sensitive code system <code>http://terminology.hl7.org/CodeSystem/research-study-purpose-type</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">treatment<a name=\"research-study-purpose-type-treatment\"> </a></td><td>Treatment Study</td><td>One or more interventions are being evaluated for treating a disease, syndrome, or condition.</td></tr><tr><td style=\"white-space:nowrap\">prevention<a name=\"research-study-purpose-type-prevention\"> </a></td><td>Prevention Study</td><td>One or more interventions are being evaluated for preventing the development of a disease or condition.</td></tr><tr><td style=\"white-space:nowrap\">diagnostic<a name=\"research-study-purpose-type-diagnostic\"> </a></td><td>Diagnostic Study</td><td>One or more methods are being evaluated for use in detecting a disease or condition, typically in persons who have symptoms or signs of the condition. For example, a mammography to evaluate a palpable mass.</td></tr><tr><td style=\"white-space:nowrap\">screening<a name=\"research-study-purpose-type-screening\"> </a></td><td>Screening Study</td><td>One or more methods are being evaluated for use in detecting a disease or condition, in people who do not yet show symptoms or signs of the condition. For example, a mammography every 2 years in a woman with no current breast concerns.</td></tr><tr><td style=\"white-space:nowrap\">supportive-care<a name=\"research-study-purpose-type-supportive-care\"> </a></td><td>Supportive Care Study</td><td>One or more interventions are being evaluated for maximizing comfort, minimizing side effects, or mitigating against a decline in the participant's health or function.</td></tr><tr><td style=\"white-space:nowrap\">health-services-research<a name=\"research-study-purpose-type-health-services-research\"> </a></td><td>Health Services Research</td><td>An investigation for evaluating the delivery, processes, management, organization, or financing of health care.</td></tr><tr><td style=\"white-space:nowrap\">basic-science<a name=\"research-study-purpose-type-basic-science\"> </a></td><td>Basic Science</td><td>An investigation to increase general scientific knowledge, such as examining the mechanism of action (for example, physiology or biomechanics) of a disease process or intervention.</td></tr><tr><td style=\"white-space:nowrap\">device-feasibility<a name=\"research-study-purpose-type-device-feasibility\"> </a></td><td>Device Feasibility Study</td><td>An intervention of a device product is being evaluated to determine the feasibility of the product or to test a prototype device and not health outcomes. Such studies are conducted to confirm the design and operating specifications of a device before beginning a full clinical trial.</td></tr><tr><td style=\"white-space:nowrap\">safety<a name=\"research-study-purpose-type-safety\"> </a></td><td>Safety Study</td><td>One or more interventions are being evaluated for associated risks or adverse events. (Note: Risks associated with interventions are evaluated in Safety Studies, whereas risks associated with conditions or non-interventional exposures are evaluated in Risk Association Studies.)</td></tr><tr><td style=\"white-space:nowrap\">risk-association<a name=\"research-study-purpose-type-risk-association\"> </a></td><td>Risk Association Study</td><td>One or more conditions or non-interventional exposures are being evaluated for associated risks or adverse events. (Note: Risks associated with interventions are evaluated in Safety Studies, whereas risks associated with conditions or non-interventional exposures are evaluated in Risk Association Studies.)</td></tr><tr><td style=\"white-space:nowrap\">efficacy<a name=\"research-study-purpose-type-efficacy\"> </a></td><td>Efficacy Study</td><td>One or more interventions are being evaluated for how well they achieve their intended purpose, such as the ability to treat or prevent a disease, syndrome, or condition.</td></tr><tr><td style=\"white-space:nowrap\">pharmacokinetic<a name=\"research-study-purpose-type-pharmacokinetic\"> </a></td><td>Pharmacokinetic Study</td><td>A study of the process or processes by which a drug is absorbed, distributed, metabolized, or eliminated by the body.</td></tr><tr><td style=\"white-space:nowrap\">pharmacodynamic<a name=\"research-study-purpose-type-pharmacodynamic\"> </a></td><td>Pharmacodynamic Study</td><td>A study of the mechanism of drug action, biochemical effect, or physiological effect of a drug.</td></tr><tr><td style=\"white-space:nowrap\">bioequivalence<a name=\"research-study-purpose-type-bioequivalence\"> </a></td><td>Bioequivalence Study</td><td>A study comparing two drug formulations to evaluate similarity in pharmacokinetic effects to determine if they are therapeutically interchangeable.</td></tr><tr><td style=\"white-space:nowrap\">dose-response<a name=\"research-study-purpose-type-dose-response\"> </a></td><td>Dose-Response Study</td><td>A study evaluating the relationship between the amount of a substance or degree of exposure and the resulting effect or biological response.</td></tr><tr><td style=\"white-space:nowrap\">pharmacogenetic<a name=\"research-study-purpose-type-pharmacogenetic\"> </a></td><td>Pharmacogenetic Study</td><td>A study evaluating how specific gene variations affect individual drug responses.</td></tr><tr><td style=\"white-space:nowrap\">pharmacogenomic<a name=\"research-study-purpose-type-pharmacogenomic\"> </a></td><td>Pharmacogenomic Study</td><td>A study evaluating how multiple gene variations affect individual drug responses.</td></tr><tr><td style=\"white-space:nowrap\">pharmacoeconomic<a name=\"research-study-purpose-type-pharmacoeconomic\"> </a></td><td>Pharmacoeconomic Study</td><td>A study evaluating the economic costs and value of a drug. This may include cost-effectiveness, cost-benefit, and cost-utility analyses.</td></tr><tr><td style=\"white-space:nowrap\">incidence<a name=\"research-study-purpose-type-incidence\"> </a></td><td>Incidence Study</td><td>A study that assesses the occurrence of new cases of disease, condition, or injury in a defined population over a specified period of time.</td></tr><tr><td style=\"white-space:nowrap\">prevalence<a name=\"research-study-purpose-type-prevalence\"> </a></td><td>Prevalence Study</td><td>A study that assesses the proportion of members of a population who have a particular disease, condition, or injury at a specified point in time or over a specified period of time.</td></tr><tr><td style=\"white-space:nowrap\">prediction<a name=\"research-study-purpose-type-prediction\"> </a></td><td>Prediction Study</td><td>One or more methods are being evaluated for use in predicting the risk of a disease or condition.</td></tr></table></div>"^^rdf:XMLLiteral ]
  ] ; # 
  fhir:extension ( [
fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg"^^xsd:anyURI ] ;
fhir:value [
a fhir:code ;
fhir:v "brr"     ]
  ] [
fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm"^^xsd:anyURI ] ;
fhir:value [
a fhir:integer ;
fhir:v 1     ]
  ] ) ; # 
  fhir:url [ fhir:v "http://terminology.hl7.org/CodeSystem/research-study-purpose-type"^^xsd:anyURI] ; # 
  fhir:version [ fhir:v "1.0.0"] ; # 
  fhir:name [ fhir:v "ResearchStudyPurposeType"] ; # 
  fhir:title [ fhir:v "Research Study Purpose Type"] ; # 
  fhir:status [ fhir:v "active"] ; # 
  fhir:experimental [ fhir:v false] ; # 
  fhir:date [ fhir:v "2026-04-14T16:55:11+11:00"^^xsd:dateTime] ; # 
  fhir:publisher [ fhir:v "Health Level Seven International"] ; # 
  fhir:contact ( [
    ( fhir:telecom [
fhir:system [ fhir:v "url" ] ;
fhir:value [ fhir:v "http://hl7.org" ]     ] [
fhir:system [ fhir:v "email" ] ;
fhir:value [ fhir:v "hq@HL7.org" ]     ] )
  ] ) ; # 
  fhir:description [ fhir:v "Codes for the intent of the study."] ; # 
  fhir:copyright [ fhir:v "This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license"] ; # 
  fhir:caseSensitive [ fhir:v true] ; # 
  fhir:valueSet [
fhir:v "http://terminology.hl7.org/ValueSet/research-study-purpose-type"^^xsd:anyURI ;
fhir:link <http://terminology.hl7.org/ValueSet/research-study-purpose-type>
  ] ; # 
  fhir:content [ fhir:v "complete"] ; # 
  fhir:concept ( [
fhir:code [ fhir:v "treatment" ] ;
fhir:display [ fhir:v "Treatment Study" ] ;
fhir:definition [ fhir:v "One or more interventions are being evaluated for treating a disease, syndrome, or condition." ]
  ] [
fhir:code [ fhir:v "prevention" ] ;
fhir:display [ fhir:v "Prevention Study" ] ;
fhir:definition [ fhir:v "One or more interventions are being evaluated for preventing the development of a disease or condition." ]
  ] [
fhir:code [ fhir:v "diagnostic" ] ;
fhir:display [ fhir:v "Diagnostic Study" ] ;
fhir:definition [ fhir:v "One or more methods are being evaluated for use in detecting a disease or condition, typically in persons who have symptoms or signs of the condition. For example, a mammography to evaluate a palpable mass." ]
  ] [
fhir:code [ fhir:v "screening" ] ;
fhir:display [ fhir:v "Screening Study" ] ;
fhir:definition [ fhir:v "One or more methods are being evaluated for use in detecting a disease or condition, in people who do not yet show symptoms or signs of the condition. For example, a mammography every 2 years in a woman with no current breast concerns." ]
  ] [
fhir:code [ fhir:v "supportive-care" ] ;
fhir:display [ fhir:v "Supportive Care Study" ] ;
fhir:definition [ fhir:v "One or more interventions are being evaluated for maximizing comfort, minimizing side effects, or mitigating against a decline in the participant's health or function." ]
  ] [
fhir:code [ fhir:v "health-services-research" ] ;
fhir:display [ fhir:v "Health Services Research" ] ;
fhir:definition [ fhir:v "An investigation for evaluating the delivery, processes, management, organization, or financing of health care." ]
  ] [
fhir:code [ fhir:v "basic-science" ] ;
fhir:display [ fhir:v "Basic Science" ] ;
fhir:definition [ fhir:v "An investigation to increase general scientific knowledge, such as examining the mechanism of action (for example, physiology or biomechanics) of a disease process or intervention." ]
  ] [
fhir:code [ fhir:v "device-feasibility" ] ;
fhir:display [ fhir:v "Device Feasibility Study" ] ;
fhir:definition [ fhir:v "An intervention of a device product is being evaluated to determine the feasibility of the product or to test a prototype device and not health outcomes. Such studies are conducted to confirm the design and operating specifications of a device before beginning a full clinical trial." ]
  ] [
fhir:code [ fhir:v "safety" ] ;
fhir:display [ fhir:v "Safety Study" ] ;
fhir:definition [ fhir:v "One or more interventions are being evaluated for associated risks or adverse events. (Note: Risks associated with interventions are evaluated in Safety Studies, whereas risks associated with conditions or non-interventional exposures are evaluated in Risk Association Studies.)" ]
  ] [
fhir:code [ fhir:v "risk-association" ] ;
fhir:display [ fhir:v "Risk Association Study" ] ;
fhir:definition [ fhir:v "One or more conditions or non-interventional exposures are being evaluated for associated risks or adverse events. (Note: Risks associated with interventions are evaluated in Safety Studies, whereas risks associated with conditions or non-interventional exposures are evaluated in Risk Association Studies.)" ]
  ] [
fhir:code [ fhir:v "efficacy" ] ;
fhir:display [ fhir:v "Efficacy Study" ] ;
fhir:definition [ fhir:v "One or more interventions are being evaluated for how well they achieve their intended purpose, such as the ability to treat or prevent a disease, syndrome, or condition." ]
  ] [
fhir:code [ fhir:v "pharmacokinetic" ] ;
fhir:display [ fhir:v "Pharmacokinetic Study" ] ;
fhir:definition [ fhir:v "A study of the process or processes by which a drug is absorbed, distributed, metabolized, or eliminated by the body." ]
  ] [
fhir:code [ fhir:v "pharmacodynamic" ] ;
fhir:display [ fhir:v "Pharmacodynamic Study" ] ;
fhir:definition [ fhir:v "A study of the mechanism of drug action, biochemical effect, or physiological effect of a drug." ]
  ] [
fhir:code [ fhir:v "bioequivalence" ] ;
fhir:display [ fhir:v "Bioequivalence Study" ] ;
fhir:definition [ fhir:v "A study comparing two drug formulations to evaluate similarity in pharmacokinetic effects to determine if they are therapeutically interchangeable." ]
  ] [
fhir:code [ fhir:v "dose-response" ] ;
fhir:display [ fhir:v "Dose-Response Study" ] ;
fhir:definition [ fhir:v "A study evaluating the relationship between the amount of a substance or degree of exposure and the resulting effect or biological response." ]
  ] [
fhir:code [ fhir:v "pharmacogenetic" ] ;
fhir:display [ fhir:v "Pharmacogenetic Study" ] ;
fhir:definition [ fhir:v "A study evaluating how specific gene variations affect individual drug responses." ]
  ] [
fhir:code [ fhir:v "pharmacogenomic" ] ;
fhir:display [ fhir:v "Pharmacogenomic Study" ] ;
fhir:definition [ fhir:v "A study evaluating how multiple gene variations affect individual drug responses." ]
  ] [
fhir:code [ fhir:v "pharmacoeconomic" ] ;
fhir:display [ fhir:v "Pharmacoeconomic Study" ] ;
fhir:definition [ fhir:v "A study evaluating the economic costs and value of a drug. This may include cost-effectiveness, cost-benefit, and cost-utility analyses." ]
  ] [
fhir:code [ fhir:v "incidence" ] ;
fhir:display [ fhir:v "Incidence Study" ] ;
fhir:definition [ fhir:v "A study that assesses the occurrence of new cases of disease, condition, or injury in a defined population over a specified period of time." ]
  ] [
fhir:code [ fhir:v "prevalence" ] ;
fhir:display [ fhir:v "Prevalence Study" ] ;
fhir:definition [ fhir:v "A study that assesses the proportion of members of a population who have a particular disease, condition, or injury at a specified point in time or over a specified period of time." ]
  ] [
fhir:code [ fhir:v "prediction" ] ;
fhir:display [ fhir:v "Prediction Study" ] ;
fhir:definition [ fhir:v "One or more methods are being evaluated for use in predicting the risk of a disease or condition." ]
  ] ) . #